PBE
PBE
About Invesco Biotechnology & Genome ETF
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings...
About Invesco Biotechnology & Genome ETF
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 AMGN | Amgen Inc. | 5.06% | 37.84K | $13.08M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 5.02% | 43.02K | $13.06M |
 RPRX | Royalty Pharma plc | 5.00% | 236.01K | $12.99M |
 BIIB | Biogen Inc. | 4.97% | 65.83K | $12.93M |
 VRTX | Vertex Pharmaceuticals Incorporated | 4.95% | 29.16K | $12.88M |
 REGN | Regeneron Pharmaceuticals, Inc. | 4.84% | 20.03K | $12.59M |
 GILD | Gilead Sciences, Inc. | 4.72% | 95.05K | $12.28M |
 UTHR | United Therapeutics Corporation | 4.63% | 21.98K | $12.04M |
 LEGN | Legend Biotech Corporation | 3.09% | 234.79K | $8.03M |
 ILMN | Illumina, Inc. | 3.08% | 47.74K | $8.02M |
 VCYT | Veracyte, Inc. | 3.01% | 156.83K | $7.83M |
 TECH | Bio-Techne Corporation | 2.95% | 144.54K | $7.69M |
 RGEN | Repligen Corporation | 2.93% | 60.19K | $7.62M |
 NBIX | Neurocrine Biosciences, Inc. | 2.86% | 44.52K | $7.45M |
 CDNA | CareDx, Inc | 2.86% | 321.89K | $7.44M |
 BMRN | BioMarin Pharmaceutical Inc. | 2.85% | 131.12K | $7.40M |
 EXEL | Exelixis, Inc. | 2.80% | 138.72K | $7.28M |
 PTCT | PTC Therapeutics, Inc. | 2.78% | 102.49K | $7.24M |
 INCY | Incyte Corporation | 2.78% | 71.41K | $7.23M |
 HALO | Halozyme Therapeutics, Inc. | 2.78% | 100.89K | $7.22M |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
United States
NetherlandsSECTOR HOLDINGS
Healthcare Financial Services Cash & OthersASSET ALLOCATION BY REGION
United States NetherlandsHoldings (Top 20)
AMGN
Amgen Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
RPRX
Royalty Pharma plc
BIIB
Biogen Inc.
VRTX
Vertex Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
GILD
Gilead Sciences, Inc.
UTHR
United Therapeutics Corporation
LEGN
Legend Biotech Corporation
ILMN
Illumina, Inc.
VCYT
Veracyte, Inc.
TECH
Bio-Techne Corporation
RGEN
Repligen Corporation
NBIX
Neurocrine Biosciences, Inc.
CDNA
CareDx, Inc
BMRN
BioMarin Pharmaceutical Inc.
EXEL
Exelixis, Inc.
PTCT
PTC Therapeutics, Inc.
INCY
Incyte Corporation
HALO
Halozyme Therapeutics, Inc.